Introduction
Patients and methods
Ceftriaxone is a broad spectrum cephalosporin with an exceptionally long plasma elimination half life of about eight hours.' 2 It is the first long acting P lactam antibiotic. The aminothiazole methoxyimino-acyl side chain gives the product good stability to P lactamase. The bioavailability of ceftriaxone after intramuscular administration is 100%. After injection, 60% of the drug is excreted in the urine and 4007 is eliminated in the bile.3 Unlike many other cephalosporins, ceftriaxone is not excreted by tubular secretion. This is shown by the fact that probenecid has no effect on its elimination half life. If gonococci persisted or reappeared within 14 days of treatment and the patient had not had further sexual intercourse, then the treatment was considered to have failed; the reappearance of gonococci after 14 days irrespective of the patient's history, was considered to be due to reinfection. Those who had had sexual exposure before the first follow up examination were excluded from the final assessment.
Postgonococcal urethritis (PGU) was diagnosed if Gram stained smears of urethral material showed more than 4 leucocytes per microscope field (x 1000) seven days after treatment.'0
STATISTICAL ANALYSIS
The unpaired t test and the x2 test were used.
Results
Of 200 patients enrolled in the study, 10 were excluded; three because N gonorrhoeae could not be cultured, one because the patient had sexual intercourse before the first follow up, and six because the patients did not return for follow up examinations. Thus there were 93 patients treated with spectinomycin and 97 patients treated with ceftriaxone for evaluation. Table I shows the results of treatment; there were no failures in either group.
Of the 197 isolates with positive culture results tested for the presence of the enzyme P lactamase, 91 (46-2%) were PPNG strains and 106 (53-8%) were non-PPNG strains. 
SENSITIVITY OF N GONORRHOEAE TO ANTIBIOTICS

SIDE EFFECTS
No side effects to either drug were reported by the patients or noted on examination.
POSTGONOCOCCAL URETHRITIS (PGU)
Of 85 men treated with spectinomycin who attended for follow up on day 7 after treatment, 31 (36 50/) had PGU. Of 85 men treated with ceftriaxone who attended for follow up on day 7, 34 (40%) had developed PGU. The difference between the two groups was not significant (X2 = 0*225; p>0-01).
Discussion
In areas where P lactamase producing gonococci are prevalent penicillin should not be used to treat gonococcal infections. Spectinomycin, cefoxitin, cefotaxime, and ceftriaxone have been recommended.7 Although there are reports from various parts of the world, including Thailand where PPNG strains are endemic, showing that spectinomycin, cefoxitin, and cefotaxime are effective in treating such infections, alternative treatments should be encouraged."18
Since 1981 PPNG strains resistant to spectinomycin have been reported. '9 20 Ceftriaxone is a new third generation cephalosporin that has been found to be active against both PPNG and non-PPNG strains.5 6 In the study published here the non-PPNG strains were more susceptible than PPNG strains to ceftriaxone, a finding noted previously by Thabaut et 
